Uni-Bio Science Group Limited (0690.HK)
HKD 0.07
(0.0%)
HKD 0.07
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 91.23 Million HKD | 22.54% |
| 2022 | 61.2 Million HKD | 1659.57% |
| 2021 | 1.31 Million HKD | 126.58% |
| 2020 | -49.94 Million HKD | -242.94% |
| 2019 | 27.37 Million HKD | 109.91% |
| 2018 | -117.26 Million HKD | -122.35% |
| 2017 | -247.86 Million HKD | -70.8% |
| 2016 | -25.47 Million HKD | 11.43% |
| 2015 | -25.51 Million HKD | -112.2% |
| 2014 | -13.56 Million HKD | -200.87% |
| 2013 | -4.51 Million HKD | -917.03% |
| 2012 | 362 Thousand HKD | 105.77% |
| 2011 | -33.28 Million HKD | -151.92% |
| 2010 | -110.67 Million HKD | 95.7% |
| 2009 | -357.75 Million HKD | -1580.32% |
| 2008 | -350.05 Million HKD | -101.3% |
| 2007 | 376.61 Million HKD | 169.39% |
| 2006 | 149.94 Million HKD | 553.28% |
| 2005 | -33.07 Million HKD | -278.26% |
| 2004 | 18.55 Million HKD | 334.04% |
| 2003 | 5.76 Million HKD | -171.73% |
| 2002 | 11.05 Million HKD | -72.88% |
| 2001 | 40.76 Million HKD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | 40.13 Million HKD | 0.0% |
| 2024 Q1 | 40.13 Million HKD | -0.53% |
| 2023 FY | - HKD | 22.54% |
| 2023 Q1 | 24.58 Million HKD | -27.35% |
| 2023 Q2 | 45.12 Million HKD | 83.56% |
| 2023 Q3 | 21.69 Million HKD | -51.93% |
| 2023 Q4 | 40.34 Million HKD | 86.01% |
| 2022 Q4 | 33.83 Million HKD | 114.67% |
| 2022 Q1 | 14 Million HKD | 895.54% |
| 2022 Q2 | 23.95 Million HKD | 71.12% |
| 2022 Q3 | 15.76 Million HKD | -34.21% |
| 2022 FY | - HKD | 1659.57% |
| 2021 Q4 | -1.76 Million HKD | -920.29% |
| 2021 Q1 | 5.61 Million HKD | 122.56% |
| 2021 Q2 | 12.61 Million HKD | 124.78% |
| 2021 Q3 | -172.5 Thousand HKD | -101.37% |
| 2021 FY | - HKD | 126.58% |
| 2020 Q2 | -6.07 Million HKD | -529.1% |
| 2020 FY | - HKD | -242.94% |
| 2020 Q4 | -24.87 Million HKD | -206.01% |
| 2020 Q3 | -8.12 Million HKD | -33.83% |
| 2020 Q1 | -965.5 Thousand HKD | 96.55% |
| 2019 Q3 | -33.11 Million HKD | -15.09% |
| 2019 Q2 | -28.77 Million HKD | -321.54% |
| 2019 Q1 | 12.98 Million HKD | 146.81% |
| 2019 FY | - HKD | 109.91% |
| 2019 Q4 | -28 Million HKD | 15.45% |
| 2018 FY | - HKD | -122.35% |
| 2018 Q1 | -24.75 Million HKD | -63.93% |
| 2018 Q3 | -27.74 Million HKD | -12.08% |
| 2018 Q2 | -24.75 Million HKD | 0.0% |
| 2018 Q4 | -27.74 Million HKD | 0.0% |
| 2017 Q2 | -10.71 Million HKD | 0.0% |
| 2017 Q1 | -10.71 Million HKD | -11.4% |
| 2017 FY | - HKD | -70.8% |
| 2017 Q4 | -15.09 Million HKD | 0.0% |
| 2017 Q3 | -15.09 Million HKD | -40.86% |
| 2016 Q4 | -9.62 Million HKD | 0.0% |
| 2016 Q1 | -5.93 Million HKD | -13.59% |
| 2016 FY | - HKD | 11.43% |
| 2016 Q3 | -9.62 Million HKD | -62.02% |
| 2016 Q2 | -5.93 Million HKD | 0.0% |
| 2015 Q3 | -5.22 Million HKD | -26.49% |
| 2015 Q4 | -5.22 Million HKD | 0.0% |
| 2015 FY | - HKD | -112.2% |
| 2015 Q1 | -4.13 Million HKD | 0.0% |
| 2015 Q2 | -4.13 Million HKD | 0.0% |
| 2014 Q4 | - HKD | 0.0% |
| 2014 FY | - HKD | -200.87% |
| 2014 Q1 | -21.49 Million HKD | 0.0% |
| 2013 FY | - HKD | -917.03% |
| 2013 Q4 | -21.49 Million HKD | -1177.82% |
| 2013 Q3 | -1.68 Million HKD | 0.0% |
| 2013 Q2 | -1.68 Million HKD | -182.96% |
| 2013 Q1 | 2.02 Million HKD | 0.0% |
| 2012 Q1 | -3.72 Million HKD | 0.0% |
| 2012 FY | - HKD | 105.77% |
| 2012 Q4 | 2.02 Million HKD | 176.87% |
| 2012 Q3 | -2.63 Million HKD | 0.0% |
| 2012 Q2 | -2.63 Million HKD | 29.19% |
| 2011 FY | - HKD | -151.92% |
| 2011 Q4 | -3.72 Million HKD | 0.0% |
| 2010 FY | - HKD | 95.7% |
| 2009 FY | - HKD | -1580.32% |
| 2008 FY | - HKD | -101.3% |
| 2007 FY | - HKD | 169.39% |
| 2006 FY | - HKD | 553.28% |
| 2005 FY | - HKD | -278.26% |
| 2004 FY | - HKD | 334.04% |
| 2003 FY | - HKD | -171.73% |
| 2002 FY | - HKD | -72.88% |
| 2001 FY | - HKD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| CK Life Sciences Int'l., (Holdings) Inc. | 486.79 Million HKD | 81.258% |